Lv42
410 积分 2024-03-29 加入
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
4小时前
已完结
Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?
12天前
已关闭
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
13天前
已完结
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
24天前
已完结
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD
24天前
已完结
Maternal first‐trimester serum vitamin A/E concentration and risk of infant atopic dermatitis within 12 months
2个月前
已完结
Atopic dermatitis
2个月前
已完结
Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials
2个月前
已关闭
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update
2个月前
已关闭
REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide
2个月前
已完结
皖公网安备34019202002308
